US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 9.940
  • +0.180+1.84%
Close Nov 29 13:00 ET
  • 9.850
  • -0.090-0.91%
Post 17:01 ET
1.61BMarket Cap8.95P/E (TTM)

About Neumora Therapeutics Company

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.

Company Profile

SymbolNMRA
Company NameNeumora Therapeutics
Listing DateSep 15, 2023
Issue Price17.00
Founded2019
CEOMr. Henry O. Gosebruch
MarketNASDAQ
Employees124
Fiscal Year Ends12-31
Address490 Arsenal Way,Suite 200
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Websitehttp://www.neumoratx.com

Company Executives

  • Name
  • Position
  • Salary
  • Henry O. Gosebruch
  • Director, President and Chief Executive Officer
  • 22.00M
  • Jason G. Duncan
  • Chief Legal Officer
  • 4.12M
  • Carol Suh
  • Chief Operating Officer
  • --
  • Dr. Joshua Pinto, PhD
  • Chief Financial Officer
  • --
  • Dr. Daljit Singh Aurora, Pharm.D.
  • Chief Strategy Officer
  • --
  • Michael Lee Milligan
  • Principal Accounting Officer
  • --
  • Paul L. Berns
  • Executive Chairman of the Board
  • 8.57M
  • Matthew K. Fust
  • Independent Director
  • 485.53K
  • David Piacquad
  • Independent Director
  • 620.76K
  • Alaa Halawa
  • Independent Director
  • 671.20K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 430.97K
  • Kristina M. Burow
  • Independent Director
  • 686.60K
  • Dr. Robert Lenz, M.D.
  • Head of Research and Development
  • 13.58M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data